Synthetic Lethality Exploitation by an Anti-Trop-2-SN-38 Antibody-Drug Conjugate, IMMU-132, Plus PARP Inhibitors in [electronic resource]
Producer: 20180503Description: 3405-3415 p. digitalISSN:- 1557-3265
- Animals
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- BRCA1 Protein -- genetics
- BRCA2 Protein -- genetics
- Camptothecin -- administration & dosage
- Cell Line, Tumor
- DNA Repair -- drug effects
- DNA Topoisomerases, Type I -- drug effects
- Drug Resistance, Neoplasm -- genetics
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Immunoconjugates -- administration & dosage
- Indoles -- administration & dosage
- Mice
- Phthalazines -- administration & dosage
- Piperazines -- administration & dosage
- Poly(ADP-ribose) Polymerase Inhibitors -- administration & dosage
- Synthetic Lethal Mutations -- genetics
- Triple Negative Breast Neoplasms -- genetics
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.